Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Trop Med Int Health ; 11(8): 1147-56, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16903878

ABSTRACT

BACKGROUND: Past studies have shown that health workers in developing countries often do not follow clinical guidelines, though few studies have explored with appropriate methods why errors occur. To develop interventions that improve health worker performance, factors affecting treatment practices must be better understood. METHODS: We analysed data from a health facility survey in Blantyre District, Malawi, in which health workers were observed treating ill children, and then children were independently re-examined by 'gold-standard' study clinicians. The analysis was limited to children with uncomplicated malaria (defined according to Malawi's guidelines as fever or anaemia without signs of severe illness), and a treatment error was defined as failure to treat with an effective antimalarial. RESULTS: Twenty-eight health workers and 349 ill-child consultations were evaluated; 247 (70.8%) children were treated with an effective antimalarial, and 102 (29.2%) were subject to treatment error. Logistic regression analysis revealed that in-service malaria training was not associated with treatment quality (univariate odds ratio (OR) = 1.16, 95% confidence interval (CI): 0.46-2.93); whereas acute respiratory infections training was associated with making an error (adjusted OR (aOR) = 2.42, 95% CI: 1.23-4.76). High fever and chief complaint of fever were associated with fewer errors (aOR = 0.25, 95% CI: 0.10-0.60 and aOR = 0.25, 95% CI: 0.13-0.48, respectively). Errors were more likely to occur in consultations starting before 1 p.m. (aOR = 1.88, 95% CI: 1.07-3.31). Supervision was not associated with better treatment quality. CONCLUSIONS: These results suggest that the disease-specific training and supervision, performed before the survey, did not lead to long-term improvements in health care quality. Furthermore, case management training for one specific disease may have worsened quality of care for another disease. These results support integration of guidelines for multiple conditions. Interventions should be evaluated for unintended negative effects on overall quality of care.


Subject(s)
Antimalarials/therapeutic use , Guideline Adherence , Inservice Training , Malaria/drug therapy , Medication Errors , Child Health Services/standards , Child, Preschool , Clinical Competence , Cross-Sectional Studies , Female , Fever/diagnosis , Fever/drug therapy , Health Care Surveys/methods , Health Personnel/education , Humans , Infant , Malaria/diagnosis , Malawi , Male , Odds Ratio , Quality of Health Care , Time Factors
2.
Am J Trop Med Hyg ; 73(3): 609-15, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16172491

ABSTRACT

In Malawi, trimethoprim-sulfamethoxazole (TS) is the recommended first-line treatment for children with Integrated Management of Childhood Illness dual classifications of malaria and pneumonia, and sulfadoxine-pyrimethyamine (SP) plus five days of treatment with erythromycin (SP plus E) is the recommended second-line treatment. Using a 14-day, modified World Health Organization protocol, children with dual IMCI classifications of malaria and pneumonia with Plasmodium falciparum parasitemia were randomized to receive TS or SP plus E. Clinical and parasitologic responses and gametocytemia prevalence were obtained. A total of 87.2% of children receiving TS and 80.0% receiving SP plus E reached adequate clinical and parasitologic responses (ACPRs) (P = 0.19). Severely malnourished children were less likely to achieve ACPRs than those better nourished (relative risk = 3.34, P = 0.03). Day 7 gametocyte prevalence was 55% and 64% among children receiving TS and SP plus E, respectively (P = 0.19). Thus, TS and SP plus E remain efficacious treatment of P. falciparum malaria in this setting. However, patient adherence and effectiveness of five days of treatment with TS is unknown.


Subject(s)
Erythromycin/therapeutic use , Malaria/drug therapy , Pneumonia, Bacterial/drug therapy , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Anti-Infective Agents/therapeutic use , Child, Preschool , Drug Combinations , Erythromycin/adverse effects , Humans , Infant , Malawi , Nutritional Status , Pyrimethamine/adverse effects , Risk Factors , Sulfadoxine/adverse effects , Treatment Failure , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects
3.
Trop Med Int Health ; 9(1): 77-82, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14728610

ABSTRACT

Malaria in pregnancy contributes to low birth weight and increased infant mortality. As part of WHO's Roll Back Malaria initiative, African heads of state pledged that by 2005, 60% of pregnant women will receive malaria chemoprophylaxis or intermittent preventive treatment (IPT). We performed a cluster sample survey to study the use of sulfadoxine-pyrimethamine (SP) for IPT among recently pregnant women in February 2000 in Blantyre District, Malawi. Among 391 women in the sample, 98.6% had attended antenatal clinic at least once and 90.2% knew that SP/IPT was recommended during pregnancy. Overall, only 36.8% received the full recommended two-dose regimen of SP/IPT. Using data from 187 women with antenatal clinic cards, we found that residence location, housing type and gender/age/education of the head of household were not associated with failure to receive SP/IPT. Adjusting for education, multigravid women were more likely not to receive the recommended SP/IPT regimen (RR 1.2, 95% CI 1.02-1.5, P=0.03). A substantial effort to improve the delivery and use of SP/IPT in Malawi will be necessary, but the Roll Back Malaria 2005 goal appears achievable.


Subject(s)
Malaria/prevention & control , Patient Acceptance of Health Care/psychology , Pregnancy Complications, Parasitic/prevention & control , Prenatal Care/statistics & numerical data , Adolescent , Adult , Age Distribution , Antimalarials/therapeutic use , Cluster Analysis , Drug Administration Schedule , Drug Combinations , Female , Humans , Malaria/epidemiology , Malawi/epidemiology , Middle Aged , Parity , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Prenatal Care/methods , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use
4.
Trans R Soc Trop Med Hyg ; 97(5): 491-7, 2003.
Article in English | MEDLINE | ID: mdl-15307408

ABSTRACT

Malaria is a leading cause of death in children aged < 5 years in Malawi. As part of the Roll Back Malaria initiative, African heads of state have pledged that by 2005, 60% of children will receive an effective antimalarial drug within 24 h of developing fever. In 1993, Malawi switched from chloroquine to sulfadoxine-pyrimethamine (SP) in its recommendations of home treatment of febrile illness in children. To study care seeking behaviour and home treatment in Blantyre District, and provide valuable follow-up to the chloroquine to SP transition, we performed a 2-stage cluster-sample survey in February 2000. Our sample of 1080 households included 672 households with children aged < 5 years; 292 (32.2%, 95% CI 28.7-35.8%) of the 912 children in these households had completed a febrile episode within the past 14 d. Among recently febrile children, 210 (72.0%, 95% CI 67.0-77.1%) received medication at home during their illness, but only 36 (12.2%, 95% CI 8.4-16.0%) received an appropriate antimalarial drug. Overall, 111 (37.4%, 95% CI 30.9-43.9%) received prompt, appropriate treatment. Only rural location was statistically associated with failure to receive prompt appropriate treatment (risk ratio estimate 1.2, 95% CI 1.01-1.5). A greater effort to improve the quality of malaria home treatment or to expand health facility utilization will be necessary to achieve Roll Back Malaria goals before 2005 in Blantyre District. Current care seeking practices suggest interventions should stress promptness of health facility visits, improved access to appropriate drugs, and accurate dosing for home-based treatments.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Antimalarials/therapeutic use , Fever/drug therapy , Malaria/drug therapy , Patient Acceptance of Health Care/statistics & numerical data , Ambulatory Care/statistics & numerical data , Child, Preschool , Cluster Analysis , Female , Fever/etiology , Health Services Accessibility , Home Nursing , Humans , Infant , Infant, Newborn , Malawi , Male , Referral and Consultation/statistics & numerical data , Rural Health , Time Factors
5.
Trop Med Int Health ; 7(3): 220-30, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11903984

ABSTRACT

OBJECTIVE: To evaluate the use of insecticide-treated bednets and the effectiveness of social marketing for their distribution. METHODS: Systematic cluster sample survey of 1080 households in 36 census enumeration areas across Blantyre district, Malawi, in February 2000. RESULTS: A total of 672 households had one or more children under 5. Bednet ownership was low (20.5% of households) overall, and significantly lower in rural areas than urban areas (6.4 vs. 29.8%, P=0.001). Only 3.3% of rural children under 5 had slept under a net the previous night, compared with 24.0% of urban children (P < 0.001). When asked why they did not own a net, nearly all (94.9%) caretakers in households without nets stated they had no money to buy them. In multivariate statistical models that controlled for the influence of house structure, urban vs. rural location, gender of the head of household, and the primary caretaker's education, rural children under 5 in households without nets experienced a statistically significant higher prevalence of malaria parasitaemia [RR (risk ratio) 4.9, 95% CI (confidence interval) 2.3-10.5] than children in households with at least one bednet. This was also true for urban children under 5 (RR 2.1, 95% CI 1.0-4.2, P=0.04). CONCLUSION: Social marketing approaches to promoting insecticide-treated nets in Blantyre District may have produced measurable health benefits for children in those households in which residents bought and used the products. Market-based approaches may take years to achieve high levels of coverage and may exaggerate inequities between urban and rural populations.


Subject(s)
Anemia/prevention & control , Bedding and Linens/statistics & numerical data , Insecticides/therapeutic use , Malaria/prevention & control , Adolescent , Adult , Aged , Anemia/epidemiology , Child , Child, Preschool , Educational Status , Female , Humans , Infant , Malaria/epidemiology , Malawi/epidemiology , Male , Middle Aged , Occupations , Poverty , Rural Population , Surveys and Questionnaires , Urban Population
6.
Malawi Med J ; 14(1): 23-6, 2002 Apr.
Article in English | MEDLINE | ID: mdl-27528922

ABSTRACT

The Blantyre Integrated Malaria Initiative (BIMI) is a district-wide malaria-control effort, supported jointly by the Government of Malawi and the United States Agency for International Development (USAID). BIMI was established in Blantyre District, Malawi in 1998 to promote sustainable and effective strategies to manage and prevent malaria-related morbidity and mortality. The goal of BIMI is to reduce malaria-related deaths among children under five-years of age by 30% by meeting the four main objectives listed in table 1. The key BIMI interventions and their expected beneficial outcomes are described in table 2. [Table: see text] [Table: see text].

SELECTION OF CITATIONS
SEARCH DETAIL
...